Liver protection and enzyme normalization

Silymarin (Milk Thistle)

Silymarin (the active complex of milk thistle) has the strongest evidence among herbal liver protectants. Multiple RCTs show meaningful reduction in liver enzymes (ALT, AST) in NAFLD and alcoholic liver disease. Hepatoprotective mechanisms are well-characterized.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Moderate to meaningful liver enzyme reduction in liver disease populations; hepatoprotective effect consistent across trials
Safety
Low Risk

Generally very well tolerated. May interact with hepatically metabolized drugs via CYP450 inhibition. Mild laxative effect at high doses.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
420-600 mg (standardized to 70-80% silymarin)
Timing
With meals, divided 2-3 times daily
Protocol Duration in Studies
12-16 weeks for enzyme normalization; ongoing for chronic liver support

Phosphatidylcholine-bound silymarin (silybin-PC) shows superior absorption.

Best Fit Profiles

  • liver enzyme elevation, NAFLD support, and medication-related liver protection

Source Links